Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States.

Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):298-306.

PMID:
16639343
2.

Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.

Pence BW, Miller WC, Gaynes BN, Eron JJ Jr.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):159-66.

PMID:
17146374
3.

Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.

Gaynes BN, Pence BW, Eron JJ Jr, Miller WC.

Psychosom Med. 2008 May;70(4):505-11. doi: 10.1097/PSY.0b013e31816aa0cc. Epub 2008 Mar 31.

4.

Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.

Pence BW, Gaynes BN, Whetten K, Eron JJ Jr, Ryder RW, Miller WC.

J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):434-44.

PMID:
16280698
5.

Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.

Proctor SL, Estroff TW, Empting LD, Shearer-Williams S, Hoffmann NG.

J Addict Med. 2013 Jan-Feb;7(1):17-24. doi: 10.1097/ADM.0b013e3182738655.

PMID:
23131838
6.

Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth.

Mellins CA, Elkington KS, Leu CS, Santamaria EK, Dolezal C, Wiznia A, Bamji M, Mckay MM, Abrams EJ.

AIDS Care. 2012;24(8):953-62. doi: 10.1080/09540121.2012.668174. Epub 2012 Apr 23.

7.

Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL; Cost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):449-58. doi: 10.1097/QAI.0b013e3181642244.

PMID:
18197121
8.

Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure.

Merlin JS, Westfall AO, Raper JL, Zinski A, Norton WE, Willig JH, Gross R, Ritchie CS, Saag MS, Mugavero MJ.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):164-70. Erratum in: J Acquir Immune Defic Syndr. 2013 May 1;63(1):e38-9.

9.

Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.

Gum AM, King-Kallimanis B, Kohn R.

Am J Geriatr Psychiatry. 2009 Sep;17(9):769-81. doi: 10.1097/JGP.0b013e3181ad4f5a.

PMID:
19700949
10.

Mental illness in metropolitan, urban and rural Georgia populations.

Reeves WC, Lin JM, Nater UM.

BMC Public Health. 2013 Apr 30;13:414. doi: 10.1186/1471-2458-13-414.

11.

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K.

Arch Gen Psychiatry. 2004 Aug;61(8):807-16.

PMID:
15289279
12.

Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast.

Whetten K, Reif SS, Napravnik S, Swartz MS, Thielman NM, Eron JJ Jr, Lowe K, Soto T.

South Med J. 2005 Jan;98(1):9-14.

PMID:
15678633
13.
15.

Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment.

Schumacher JE, McCullumsmith C, Mugavero MJ, Ingle-Pang PE, Raper JL, Willig JH, You Z, Batey DS, Crane H, Lawrence ST, Wright C, Treisman G, Saag MS.

AIDS Behav. 2013 Oct;17(8):2781-91. doi: 10.1007/s10461-012-0342-7.

16.

A brief mental health and substance abuse screener for persons with HIV.

Whetten K, Reif S, Swartz M, Stevens R, Ostermann J, Hanisch L, Eron JJ Jr.

AIDS Patient Care STDS. 2005 Feb;19(2):89-99.

PMID:
15716640
17.

First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: results from the Netherlands Mental Health Survey and Incidence Study-2.

de Graaf R, ten Have M, Tuithof M, van Dorsselaer S.

J Affect Disord. 2013 Jul;149(1-3):100-7. doi: 10.1016/j.jad.2013.01.009. Epub 2013 Feb 9.

PMID:
23399481
18.

Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters.

Mellins CA, Brackis-Cott E, Leu CS, Elkington KS, Dolezal C, Wiznia A, McKay M, Bamji M, Abrams EJ.

J Child Psychol Psychiatry. 2009 Sep;50(9):1131-8. doi: 10.1111/j.1469-7610.2009.02069.x. Epub 2009 Feb 27.

19.

The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.

Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM.

AIDS Patient Care STDS. 2008 Mar;22(3):233-43. doi: 10.1089/apc.2007.0092.

PMID:
18290749
20.

Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.

de Graaf R, Bijl RV, Spijker J, Beekman AT, Vollebergh WA.

Soc Psychiatry Psychiatr Epidemiol. 2003 Jan;38(1):1-11.

PMID:
12563553

Supplemental Content

Support Center